LISTERINE® – proud supporter of Oral Health Conference. Johnson & Johnson Ltd., the makers of LISTERINE®, are proud to support the Oral Health Conference (OHC) presented by the BSDHT.

On the Saturday 26th November, Professor Iain Chapple will be presenting the plenary session from 15.25 – 16.10 on ‘Time to take gingivitis seriously – why we got it wrong for the last 50 years’ sponsored by Johnson & Johnson Ltd. New data reveals that for patients who brush and fl oss, adding LISTERINE® reduces interproximal plaque by 28.4% versus brushing and flossing alone (Milleman J et al, 2022).1* And, for those who don’t floss, LISTERINE® is shown to reduce interproximal plaque above the gumline by 4.6x versus floss (Bosma ML et al, 2022).2**

Of course, not all patients are the same – attack plaque from every angle. Make an evidence-based recommendation with LISTERINE®.

For further information, visit listerineprofessional.co.uk

* Sustained plaque reduction above the gumline with continual twice daily use for 12 weeks after a dental cleaning. Flossing underwent once daily supervision on weekdays. Use LISTERINE® as part of a 3-step routine.

** Sustained plaque reduction above the gumline with continual twice daily use for 12 weeks after a dental cleaning. Flossing was performed by a dental hygienist.

References

1 Milleman J et al. Comparative e_ ectiveness of toothbrushing, flossing and mouthrinse regimens on plaque and gingivitis: a 12-week virtually supervised clinical trial. Journal of Dental Hygiene 2022; 96(3): 21-34

2 Bosma ML et al. E_ cacy of fl ossing and mouthrinsing regimens on plaque and gingivitis: a randomized clinical trial. Journal of Dental Hygiene 2022; 96(3): 8-20